◂
sci
hub
to open science
Mutual aid
↓save
. (2015).
Rituximab re-treatment as needed preferred option in RA. PharmacoEconomics & Outcomes News, 720(1), 29–29.
doi:10.1007/s40274-015-1868-5
An interview with Sci-Hub Founder Alexandra Elbakyan,Who exactly should pay for academic research
